These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 8381037)

  • 61. Gestational trophoblastic disease: selected clinical aspects and chorionic gondadotropin test methods.
    Brewer JI; Halpern B; Torok EE
    Curr Probl Cancer; 1979 Apr; 3(10):1-42. PubMed ID: 223814
    [No Abstract]   [Full Text] [Related]  

  • 62. [Molar pregnancy. Retrospective study of 60 cases in Tunisia].
    Chechia A; Koubâa A; Makhlouf T; Anis B; Terras K; Hamouda B; Mezni F
    Tunis Med; 2001; 79(8-9):441-6. PubMed ID: 11774786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Practical issues in the management of low-risk gestational trophoblast tumors.
    Savage P; Seckl M; Short D
    J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease.
    Morrow CP; Kletzky OA; Disaia PJ; Townsend DE; Mishell DR; Nakamura RM
    Am J Obstet Gynecol; 1977 Jun; 128(4):424-30. PubMed ID: 194480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Choriocarcinoma and gestational trophoblastic disease.
    Smith HO; Kohorn E; Cole LA
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):661-84. PubMed ID: 16310678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of risk factors for persistent gestational trophoblastic disease.
    Khoo SK; Baartz D; Sidhu M; Yip WL; Tripcony L
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):657-9. PubMed ID: 20070718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.
    Kohorn EI
    Obstet Gynecol; 1982 Jan; 59(1):78-84. PubMed ID: 6281702
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hydatidiform mole in Turkey: results from six centers.
    Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C
    J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Gestational trophoblastic neoplasms].
    Cruzat L; Mayerson D; Wild R; Fernández M
    Rev Chil Obstet Ginecol; 1985; 50(2):95-106. PubMed ID: 3033754
    [No Abstract]   [Full Text] [Related]  

  • 72. Modern management of gestational trophoblastic disease.
    McDonald TW; Ruffolo EH
    Obstet Gynecol Surv; 1983 Feb; 38(2):67-83. PubMed ID: 6300738
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management.
    Goldstein DP; Berkowitz RS
    Major Probl Obstet Gynecol; 1982; 14():1-301. PubMed ID: 6273659
    [No Abstract]   [Full Text] [Related]  

  • 75. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma.
    Brewer JI; Eckman TR; Dolkart RE; Torok EE; Webster A
    Am J Obstet Gynecol; 1971 Jan; 109(2):335-40. PubMed ID: 5539127
    [No Abstract]   [Full Text] [Related]  

  • 76. Understanding hydatidiform mole.
    Digiulio M; Wiedaseck S; Monchek R
    MCN Am J Matern Child Nurs; 2012; 37(1):30-4. PubMed ID: 22157338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
    Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
    Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A plea for the creation of trophoblastic disease reference centers in France].
    Golfier F; Frappart L; Schott AM; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):538-47. PubMed ID: 11084460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human immunodeficiency virus in gestational trophoblastic neoplasias--is it a poor prognostic risk factor.
    Ojwang SB; Otieno MR; Khan KS
    East Afr Med J; 1992 Nov; 69(11):647-8. PubMed ID: 1284342
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trophoblastic disease: analysis of 342 patients.
    Nakano R; Sasaki K; Yamoto M; Hata H
    Gynecol Obstet Invest; 1980; 11(4):237-42. PubMed ID: 6256264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.